JP Morgan Chase
ATOS icon

JP Morgan Chase’s Atossa Therapeutics ATOS Stock Holding History

JP Morgan Chase’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$772 Buy
390
+7
+2% +$32 ﹤0.01% 7367
2026
Q1 		$1.8K Sell
383
-2,155
-85% -$13.6K ﹤0.01% 7034
2025
Q4 		$22.5K Sell
2,538
-10
-0.4% -$126 ﹤0.01% 6476
2025
Q3 		$33.1K Buy
2,548
+2,365
+1,292% +$29.2K ﹤0.01% 6360
2025
Q2 		$2.27K Sell
183
-7,746
-98% -$92.6K ﹤0.01% 6520
2025
Q1 		$80K Sell
7,929
-16,157
-67% -$196K ﹤0.01% 5672
2024
Q4 		$341K Buy
24,086
+14,110
+141% +$275K ﹤0.01% 5237
2024
Q3 		$227K Buy
9,976
+6,376
+177% +$129K ﹤0.01% 5347
2024
Q2 		$64.3K Buy
3,600
+3,594
+59,900% +$79.5K ﹤0.01% 5747
2024
Q1 		$169 Hold
6
– – ﹤0.01% 6828
2023
Q4 		$83 Hold
6
– – ﹤0.01% 7142
2023
Q3 		$69 Hold
6
– – ﹤0.01% 6954
2023
Q2 		$118 Hold
6
– – ﹤0.01% 6679
2023
Q1 		$0 Hold
6
– – ﹤0.01% 6678
2022
Q4 		$0 Hold
6
– – ﹤0.01% 6531
2022
Q3 		$0 Hold
6
– – ﹤0.01% 6447
2022
Q2 		$0 Sell
6
-3,658
-100% -$57.6K ﹤0.01% 6450
2022
Q1 		$69K Buy
3,664
+779
+27% +$15.8K ﹤0.01% 5660
2021
Q4 		$69K Sell
2,885
-2,320
-45% -$84.9K ﹤0.01% 5820
2021
Q3 		$254K Sell
5,205
-5,217
-50% -$303K ﹤0.01% 5107
2021
Q2 		$988K Buy
+10,422
New +$552K ﹤0.01% 4305
2019
Q4 		– Sell
-757
Closed -$22K – 5599
2019
Q3 		$22K Buy
+757
New +$24K ﹤0.01% 5389

Other funds holding ATOS

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase's ATOS Position: Q2 2026 in Review

JP Morgan Chase increased its Atossa Therapeutics (ATOS) stake by 1.8% in Q2 2026, buying an estimated $32 and bringing the position to 390 shares worth $772. The position accounts for ﹤0.01% of the portfolio, ranked #7367.

JP Morgan Chase first reported a position in ATOS in Q3 2019 and has held it in 22 quarters since. The position peaked at $988K in Q2 2021. 31 funds tracked by Wall St. Rank hold ATOS as of Q2 2026.

  • JP Morgan Chase held 390 shares of Atossa Therapeutics worth $772 as of Q2 2026.
  • JP Morgan Chase bought 7 Atossa Therapeutics shares in Q2 2026, an estimated $32.
  • Atossa Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7367 holding.
  • JP Morgan Chase first reported a position in Atossa Therapeutics in Q3 2019 and has held it in 22 quarters since.
  • JP Morgan Chase's Atossa Therapeutics position peaked at $988K in Q2 2021.
  • 31 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.